DK3318881T3 - Fremgangsmåde til overvågning af Gaucher's sygdom - Google Patents

Fremgangsmåde til overvågning af Gaucher's sygdom Download PDF

Info

Publication number
DK3318881T3
DK3318881T3 DK17206796.9T DK17206796T DK3318881T3 DK 3318881 T3 DK3318881 T3 DK 3318881T3 DK 17206796 T DK17206796 T DK 17206796T DK 3318881 T3 DK3318881 T3 DK 3318881T3
Authority
DK
Denmark
Prior art keywords
gaucher
disease
monitoring
monitoring gaucher
Prior art date
Application number
DK17206796.9T
Other languages
Danish (da)
English (en)
Inventor
Hermann Mascher
Arndt Rolfs
Original Assignee
Centogene Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44652046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3318881(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centogene Gmbh filed Critical Centogene Gmbh
Application granted granted Critical
Publication of DK3318881T3 publication Critical patent/DK3318881T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442Chitinase (3.2.1.14)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • G01N2405/10Glycosphingolipids, e.g. cerebrosides, gangliosides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK17206796.9T 2011-06-06 2012-06-06 Fremgangsmåde til overvågning af Gaucher's sygdom DK3318881T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11004597A EP2533051A1 (en) 2011-06-06 2011-06-06 Method for the diagnosis of Gaucher's disease
EP12728976.7A EP2718725B1 (en) 2011-06-06 2012-06-06 Method for the diagnosis of gaucher's disease

Publications (1)

Publication Number Publication Date
DK3318881T3 true DK3318881T3 (da) 2020-09-28

Family

ID=44652046

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12728976.7T DK2718725T3 (en) 2011-06-06 2012-06-06 Procedure for the diagnosis of Gaucher's disease
DK17206796.9T DK3318881T3 (da) 2011-06-06 2012-06-06 Fremgangsmåde til overvågning af Gaucher's sygdom

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK12728976.7T DK2718725T3 (en) 2011-06-06 2012-06-06 Procedure for the diagnosis of Gaucher's disease

Country Status (15)

Country Link
US (3) US10859580B2 (cg-RX-API-DMAC7.html)
EP (4) EP2533051A1 (cg-RX-API-DMAC7.html)
JP (2) JP6120832B2 (cg-RX-API-DMAC7.html)
CN (1) CN103582818B (cg-RX-API-DMAC7.html)
AU (2) AU2012266768B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013031431B1 (cg-RX-API-DMAC7.html)
CA (1) CA2837609C (cg-RX-API-DMAC7.html)
DK (2) DK2718725T3 (cg-RX-API-DMAC7.html)
ES (2) ES2820361T3 (cg-RX-API-DMAC7.html)
IL (2) IL229607B (cg-RX-API-DMAC7.html)
NO (1) NO2718725T3 (cg-RX-API-DMAC7.html)
PL (2) PL2718725T3 (cg-RX-API-DMAC7.html)
PT (2) PT2718725T (cg-RX-API-DMAC7.html)
RU (1) RU2666952C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012167925A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893609A1 (en) * 2012-12-11 2014-06-19 Centogene Ag Method for the diagnosis of metachromatic leukodystrophy
WO2015121855A1 (en) * 2014-02-11 2015-08-20 Yeda Research And Development Co. Ltd. Marker of neuropathic gaucher's disease and methods of use thereof
CN105463085A (zh) * 2015-12-11 2016-04-06 上海新培晶医学检验所有限公司 一种检测戈谢病gba基因突变的试剂盒及其检测方法
EP3264092A1 (en) 2016-07-01 2018-01-03 Centogene AG Use of lyso-gb1 as druggable target
RU2629626C1 (ru) * 2016-10-05 2017-08-30 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ оценки эффективности лечения болезни Гоше у детей
CA3201604A1 (en) 2020-12-08 2022-06-16 Todd Frank OVOKAITYS Methods and systems for increased production of stem cells
EP4533105A1 (en) * 2022-06-01 2025-04-09 Universiteit Antwerpen Method for detecting lysosomal storage disease biomarkers and kits for performing the method
WO2024211616A1 (en) * 2023-04-04 2024-10-10 Ovokaitys Todd Frank Methods and systems for improved therapies of genetic diseases using photo-activated allogenic stem cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236838A (en) 1988-12-23 1993-08-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
UA63743A (en) * 2003-06-09 2004-01-15 Kyiv P Shupyk Medical Academy Method for diagnosing gaucher disease
EP1528056A1 (en) 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
CN104771402A (zh) * 2005-06-08 2015-07-15 阿米库斯治疗学公司 溶酶体酶编码基因突变相关的cns紊乱的治疗
BRPI0713442A2 (pt) 2006-06-23 2012-03-06 Amicus Therapeutics, Inc. Método para o tratamento de desrodens neurológicas, pelo aumento da atividade de b-glicocerebrosidase
AU2008240138B2 (en) * 2007-04-13 2013-03-07 Amicus Therapeutics, Inc. Treatment of Gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
CA2685332A1 (en) 2007-04-26 2008-11-06 Amicus Therapeutics, Inc. Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
CN101754682B (zh) * 2007-05-16 2014-11-12 布里格姆妇女医院 突触核蛋白病的治疗
GB2480159A (en) * 2008-11-14 2011-11-09 Parkinson S Inst Compositions and methods for the treatment of altered a-synuclein function

Also Published As

Publication number Publication date
CA2837609C (en) 2023-04-18
EP3318881B1 (en) 2020-07-15
AU2012266768B2 (en) 2017-06-29
PL2718725T3 (pl) 2018-06-29
PL3318881T3 (pl) 2021-02-08
DK2718725T3 (en) 2018-03-26
ES2820361T3 (es) 2021-04-20
ES2659753T3 (es) 2018-03-19
IL229607B (en) 2018-07-31
US11092609B2 (en) 2021-08-17
CN103582818A (zh) 2014-02-12
US20180259538A1 (en) 2018-09-13
AU2017232226B2 (en) 2019-12-19
WO2012167925A1 (en) 2012-12-13
EP3318881A1 (en) 2018-05-09
CN103582818B (zh) 2018-06-05
RU2018129872A (ru) 2019-03-15
EP2533051A1 (en) 2012-12-12
US20140187439A1 (en) 2014-07-03
CA2837609A1 (en) 2012-12-13
JP6514256B2 (ja) 2019-05-15
AU2017232226A1 (en) 2017-10-12
RU2666952C2 (ru) 2018-09-13
IL260078B (en) 2020-10-29
NO2718725T3 (cg-RX-API-DMAC7.html) 2018-05-12
JP2014517308A (ja) 2014-07-17
JP2017161528A (ja) 2017-09-14
PT2718725T (pt) 2018-03-07
IL260078A (en) 2018-07-31
EP2718725A1 (en) 2014-04-16
PT3318881T (pt) 2020-09-16
RU2018129872A3 (cg-RX-API-DMAC7.html) 2021-11-08
EP2718725B1 (en) 2017-12-13
BR112013031431B1 (pt) 2023-02-07
US20220011321A1 (en) 2022-01-13
JP6120832B2 (ja) 2017-04-26
US10859580B2 (en) 2020-12-08
EP3742168A1 (en) 2020-11-25
RU2013158667A (ru) 2015-07-20
IL229607A0 (en) 2014-01-30
BR112013031431A2 (pt) 2016-12-13

Similar Documents

Publication Publication Date Title
IL280839B (en) Method and system for monitoring hemodynamics
EP2688503A4 (en) ablation
IL241751A0 (en) Method of monitoring patient compliance
HUE058093T2 (hu) Eljárás alfa-amilázok szkrínelésére
DK3448034T3 (da) Fremgangsmåde til at udlede bevægelsesinformation
BR112012015988A2 (pt) método
DK3829176T3 (da) Fremgangsmåde til at konstruere fletningsliste
BR112014009795A2 (pt) método
BR112014007958A2 (pt) método
DK2732131T3 (da) Positioneringsfremgangsmåde
BR112014001851A2 (pt) método
BR112014001237A2 (pt) método
BR112014011913A2 (pt) método de perfuração
LT2991350T (lt) Vaizdų dekodavimo būdas
DK2667892T3 (da) RSV-vaccineringsprogram
DK3318881T3 (da) Fremgangsmåde til overvågning af Gaucher's sygdom
FI20115204L (fi) Menetelmä kemikaalien talteenottamiseksi
BR112013009024A2 (pt) método
BR112012023891A2 (pt) método
EP2530464A4 (en) METHOD FOR MEASURING -AMYLOID
EP2531626A4 (en) EXTRACTION PROCESS
FR2990242B1 (fr) Procede de demontage d'un turboreacteur
BR112013015601A2 (pt) método para produzir 2-(triazinilcarbonil) sulfonanilidas
FI20105620A7 (fi) Menetelmä katalyytin talteenottamiseksi
HUE056468T2 (hu) Eljárás mikrokapszulák nyerésére